AU Patent

AU2005305460B2 — Stable atorvastatin formulations

Assigned to Dexcel Pharma Technologies Ltd · Expires 2011-04-21 · 15y expired

What this patent protects

Patent listed against atrasentan-hydrochloride.

Drugs covered by this patent

atrasentan-hydrochloride (ATRASENTAN HYDROCHLORIDE)

Patent Metadata

Patent number: AU2005305460B2
Jurisdiction: AU
Classification: —
Expires: 2011-04-21
Drug substance claim: No
Drug product claim: No
Assignee: Dexcel Pharma Technologies Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.